Abstract
Darolutamide (NUBEQA (TM)) is a structurally distinct non-steroidal androgen receptor antagonist being developed by Orion and Bayer as a treatment for......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
